In our practice we try to avoid technical terms when referring to premium lenses. ” Multifocal”, “pseudo accommodating”, “apodization”, etc., tend to be very confusing for patients. Instead, we try to simplify it. Many practices will use the term “premium lenses”. However, many patients are put off by the concept of “premium” in any form. ...
Q. What is LASIK?
A. LASIK is a procedure that improves vision by changing the shape of the cornea with a laser and is a very effective treatment for a wide range of vision problems. LASIK continues to grow in popularity and is the number one elective surgery in the country.
Q. Why do people have LASIK ...
Understanding IOL Calculations
Accurate preoperative biometry is essential to attaining optimal results with the AcrySof® ReSTOR® IOL. These precise measurements of the shape and size of the eye help ensure that proper IOL power is implanted, potentially providing freedom from glasses. Preoperative biometry measurements include axial length and corneal curvature.
Axial Length
Axial length is the distance from ...
REASSURE, REASSURE, REASSURE and then reassure the patient some more!
If they come in post operatively and are not seeing the pre operative goal (vision) REASSURE the patient that not everyone sees perfectly the day after surgery and remind them that visual fluctuation is perfectly NORMAL. We will not consider a patient for retreatment for at least ...
South San Francisco, Calif. – June 22, 2010 – Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Lucentis® (ranibizumab injection) for the treatment of macular edema following retinal vein occlusion (RVO). The FDA approved this new indication after a ...